201 related articles for article (PubMed ID: 30674537)
1. Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.
Shields BD; Koss B; Taylor EM; Storey AJ; West KL; Byrum SD; Mackintosh SG; Edmondson R; Mahmoud F; Shalin SC; Tackett AJ
Cancer Res; 2019 Mar; 79(6):1113-1123. PubMed ID: 30674537
[TBL] [Abstract][Full Text] [Related]
2. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
[TBL] [Abstract][Full Text] [Related]
3. CD103
Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
[TBL] [Abstract][Full Text] [Related]
4. CD103
Edwards J; Wilmott JS; Madore J; Gide TN; Quek C; Tasker A; Ferguson A; Chen J; Hewavisenti R; Hersey P; Gebhardt T; Weninger W; Britton WJ; Saw RPM; Thompson JF; Menzies AM; Long GV; Scolyer RA; Palendira U
Clin Cancer Res; 2018 Jul; 24(13):3036-3045. PubMed ID: 29599411
[No Abstract] [Full Text] [Related]
5. Recruitment of CD103
Williford JM; Ishihara J; Ishihara A; Mansurov A; Hosseinchi P; Marchell TM; Potin L; Swartz MA; Hubbell JA
Sci Adv; 2019 Dec; 5(12):eaay1357. PubMed ID: 31844672
[TBL] [Abstract][Full Text] [Related]
6. CD103
Miao X; Chen Y; Hao K; Zheng M; Chen B; Li K; Wang Y; Zhang W; Zhang Y; Mou X; Jiang S; Wang Z
Oncol Res; 2018 Mar; 26(2):173-182. PubMed ID: 28109087
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8
Jevtovic A; Pantic J; Jovanovic I; Milovanovic M; Stanojevic I; Vojvodic D; Arsenijevic N; Lukic ML; Radosavljevic GD
Cancer Immunol Immunother; 2020 Aug; 69(8):1461-1475. PubMed ID: 32285171
[TBL] [Abstract][Full Text] [Related]
8. Small molecule AZD4635 inhibitor of A
Borodovsky A; Barbon CM; Wang Y; Ye M; Prickett L; Chandra D; Shaw J; Deng N; Sachsenmeier K; Clarke JD; Linghu B; Brown GA; Brown J; Congreve M; Cheng RK; Dore AS; Hurrell E; Shao W; Woessner R; Reimer C; Drew L; Fawell S; Schuller AG; Mele DA
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727810
[TBL] [Abstract][Full Text] [Related]
9. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Salmon H; Idoyaga J; Rahman A; Leboeuf M; Remark R; Jordan S; Casanova-Acebes M; Khudoynazarova M; Agudo J; Tung N; Chakarov S; Rivera C; Hogstad B; Bosenberg M; Hashimoto D; Gnjatic S; Bhardwaj N; Palucka AK; Brown BD; Brody J; Ginhoux F; Merad M
Immunity; 2016 Apr; 44(4):924-38. PubMed ID: 27096321
[TBL] [Abstract][Full Text] [Related]
10. Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.
Basher F; Dhar P; Wang X; Wainwright DA; Zhang B; Sosman J; Ji Z; Wu JD
J Hematol Oncol; 2020 Jun; 13(1):74. PubMed ID: 32517713
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
[TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
13. T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
French JJ; Cresswell J; Wong WK; Seymour K; Charnley RM; Kirby JA
Br J Cancer; 2002 Oct; 87(9):1034-41. PubMed ID: 12434297
[TBL] [Abstract][Full Text] [Related]
14. Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity.
Smyth LJ; Kirby JA; Cunningham AC
Clin Exp Immunol; 2007 Jul; 149(1):162-70. PubMed ID: 17403056
[TBL] [Abstract][Full Text] [Related]
15. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
16. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
17. Intrinsically altered lung-resident γδT cells control lung melanoma by producing interleukin-17A in the elderly.
Cheng M; Chen Y; Huang D; Chen W; Xu W; Chen Y; Shen G; Xu T; Shen G; Tian Z; Hu S
Aging Cell; 2020 Feb; 19(2):e13099. PubMed ID: 31903715
[TBL] [Abstract][Full Text] [Related]
18. The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours.
Zhao Y; Li J; Ting KK; Chen J; Coleman P; Liu K; Wan L; Moller T; Vadas MA; Gamble JR
Cancer Lett; 2021 Jan; 496():1-15. PubMed ID: 32991950
[TBL] [Abstract][Full Text] [Related]
19. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.
Webb JR; Milne K; Nelson BH
Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Banchereau R; Chitre AS; Scherl A; Wu TD; Patil NS; de Almeida P; Kadel Iii EE; Madireddi S; Au-Yeung A; Takahashi C; Chen YJ; Modrusan Z; McBride J; Nersesian R; El-Gabry EA; Robida MD; Hung JC; Kowanetz M; Zou W; McCleland M; Caplazi P; Eshgi ST; Koeppen H; Hegde PS; Mellman I; Mathews WR; Powles T; Mariathasan S; Grogan J; O'Gorman WE
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
